Oral immunotherapy for food allergy: Mechanisms and role in management

Clinical and Experimental Allergy

Volumn 45, Issue 2, 2015, Pages 368-383

  Nowak Wegrzyn, A ^a   Albin, S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSTIMULATING AGENT; ALLERGEN;

DESENSITIZATION; EGG ALLERGY; FOOD ALLERGY; HUMAN; IMMUNOMODULATION; MEDICATION COMPLIANCE; MILK ALLERGY; MULTICENTER STUDY (TOPIC); ORAL IMMUNOTHERAPY; PATIENT SAFETY; PEANUT ALLERGY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; ADVERSE EFFECTS; ANIMAL; CLINICAL TRIAL (TOPIC); DISEASE MANAGEMENT; FOOD; FOOD HYPERSENSITIVITY; IMMUNOLOGY; PROCEDURES; TREATMENT OUTCOME;

ALLERGENS; ANIMALS; CLINICAL TRIALS AS TOPIC; DESENSITIZATION, IMMUNOLOGIC; DISEASE MANAGEMENT; FOOD; FOOD HYPERSENSITIVITY; HUMANS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84923091641     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12382     Document Type: Review

References (100)

1. Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol 2013; 133:291-307.
2. Nwaru BI, Hickstein L, Panesar SS et al. The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy 2013; 69:62-75.
3. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191-3.
4. Panesar SS, Javad S, de Silva D et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy 2013; 68:1353-61.
5. Osborne NJ, Koplin JJ, Martin PE et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol 2011; 127:668-76.e1-2.
6. Venter C, Hasan Arshad S, Grundy J et al. Time trends in the prevalence of peanut allergy: three cohorts of children from the same geographical location in the UK. Allergy 2010; 65:103-8.
7. Boyce JA, Assa'ad A, Burks AW et al. Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol 2010; 126:1105-18.
8. Venter C, Arshad SH. Guideline fever: an overview of DRACMA, US NIAID and UK NICE guidelines. Curr Opin Allergy Clin Immunol 2012; 12:302-15.
9. Nowak-Wegrzyn A, Sampson HA. Future therapies for food allergies. J Allergy Clin Immunol 2011; 127:558-73; quiz 74-5.
10. Schofield A. A case of egg poisoning. Lancet 1908; 171:716.
11. Burks AW, Jones SM, Wood RA et al. Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012; 367:233-43.
12. Anagnostou KIS, King Y, Foley L et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 2014; 383:1297-304.
13. Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW. Successful oral tolerance induction in severe peanut allergy. Allergy 2009; 64:1218-20.
14. Blumchen K, Ulbricht H, Staden U et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010; 126:83-91.
15. Jones SM, Pons L, Roberts JL et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009; 124:292-300.e1-97.
16. Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT. Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy. J Allergy Clin Immunol 2011; 127:1622-4.
17. Keet CA, Seopaul S, Knorr S, Narisety S, Skripak J, Wood RA. Long-term follow-up of oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2013; 132:737-9.e6.
18. Longo G, Barbi E, Berti I et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008; 121:343-7.
19. Narisety SD, Skripak JM, Steele P et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol 2009; 124:610-2.
20. Skripak JM, Nash SD, Rowley H et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 2008; 122:1154-60.
21. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004; 59:980-7.
22. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 2007; 62:1261-9.
23. Vickery BP, Pons L, Kulis M, Steele P, Jones SM, Burks AW. Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 2010; 105:444-50.
24. Burks AW, Jones SM. Egg oral immunotherapy in non-anaphylactic children with egg allergy: follow-up. J Allergy Clin Immunol 2008; 121:270-1.
25. Morisset M, Moneret-Vautrin DA, Guenard L et al. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy. Eur Ann Allergy Clin Immunol 2007; 39:12-9.
26. Patriarca C, Romano A, Venuti A et al. Oral specific hyposensitization in the management of patients allergic to food 1. Allergol Immunopathol (Madr) 1984; 12:275-81.
27. Patriarca G, Schiavino D, Nucera E, Schinco G, Milani A, Gasbarrini GB. Food allergy in children: results of a standardized protocol for oral desensitization 1. Hepatogastroenterology 1998; 45:52-8.
28. Patriarca G, Nucera E, Roncallo C et al. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 2003; 17:459-65.
29. Brozek JL, Terracciano L, Hsu J et al. Oral immunotherapy for IgE-mediated cow's milk allergy: a systematic review and meta-analysis. Clin Exp Allergy 2012; 42:363-74.
30. Nurmatov U, Devereux G, Worth A, Healy L, Sheikh A. Effectiveness and safety of orally administered immunotherapy for food allergies: a systematic review and meta-analysis. Br J Nutr 2014; 111:12-22.
31. Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A. Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012; 9:CD009014.
32. Berin MC, Sampson HA. Mucosal immunology of food allergy. Curr Biol 2013; 23:R389-400.
33. Leonard SA, Martos G, Wang W, Nowak-Wegrzyn A, Berin MC. Oral immunotherapy induces local protective mechanisms in the gastrointestinal mucosa. J Allergy Clin Immunol 2012; 129:1579-87.e1.
34. Varshney P, Steele PH, Vickery BP et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 2009; 124:1351-2.
35. Yu GP, Weldon B, Neale-May S, Nadeau KC. The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial. Int Arch Allergy Immunol 2012; 159:179-82.
36. Thyagarajan A, Jones SM, Calatroni A et al. Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy 2012; 42:1197-205.
37. Kulis M, Saba K, Kim EH et al. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J Allergy Clin Immunol 2012; 129:1159-62.
38. Vickery BP, Lin J, Kulis M et al. Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol 2013; 131:128-34.e1-3.
39. Varshney P, Jones SM, Scurlock AM et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011; 127:654-60.
40. Syed A, Garcia MA, Lyu SC et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 2014; 133:500-10.e11.
41. Vickery BP, Scurlock AM, Jones SM, Burks AW. Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol 2011; 127:576-84; quiz 85-6.
42. Rolinck-Werninghaus C, Staden U, Mehl A, Hamelmann E, Beyer K, Niggemann B. Specific oral tolerance induction with food in children: transient or persistent effect on food allergy?. Allergy 2005; 60:1320-2.
43. Vickery BP, Scurlock AM, Kulis M et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 2013; 133:468-75.
44. Sicherer SH, Wood RA. Advances in diagnosing peanut allergy. J Allergy Clin Immunol Pract 2013; 1:1-13; quiz 4.
45. Pajno GB, Caminiti L, Salzano G et al. Comparison between two maintenance feeding regimens after successful cow's milk oral desensitization. Pediatr Allergy Immunol 2013; 24:376-81.
46. Hofmann AM, Scurlock AM, Jones SM et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009; 124:286-91, 91.e1-6.
47. Sampson HA. Peanut oral immunotherapy: is it ready for clinical practice? J Allergy Clin Immunol Pract 2013; 1:15-21.
48. Wood RA, Sampson HA. Oral immunotherapy for the treatment of peanut allergy: is it ready for prime time? J Allergy Clin Immunol Pract 2014; 2:97-8.
49. Sanchez-Garcia S, Rodriguez Del Rio P, Escudero C, Martinez-Gomez MJ, Ibanez MD. Possible eosinophilic esophagitis induced by milk oral immunotherapy. J Allergy Clin Immunol 2012; 129:1155-7.
50. Carraro S, Frigo AC, Perin M et al. Impact of oral immunotherapy on quality of life in children with cow milk allergy: a pilot study. Int J Immunopathol Pharmacol 2012; 25:793-8.
51. Factor JM, Mendelson L, Lee J, Nouman G, Lester MR. Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol 2012; 109:348-52.e2.
52. Otani IM, Begin P, Kearney C et al. Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects. Allergy Asthma Clin Immunol 2014; 10:25.
53. Fisher HR, du Toit G, Lack G. Specific oral tolerance induction in food allergic children: is oral desensitisation more effective than allergen avoidance?: a meta-analysis of published RCTs. Arch Dis Child 2011; 96:259-64.
54. de Boissieu D, Dupont C. Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy 2006; 61:1238-9.
55. Enrique E, Malek T, Pineda F et al. Sublingual immunotherapy for hazelnut food allergy: a follow-up study. Ann Allergy Asthma Immunol 2008; 100:283-4.
56. Enrique E, Pineda F, Malek T et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract 2. J Allergy Clin Immunol 2005; 116:1073-9.
57. Fernandez-Rivas M, Garrido Fernandez S, Nadal JA et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009; 64:876-83.
58. Kerzl R, Simonowa A, Ring J, Ollert M, Mempel M. Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol 2007; 119:507-8.
59. Fleischer DM, Burks AW, Vickery BP et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013; 131:119-27.e1-7.
60. Chin SJ, Vickery BP, Kulis MD et al. Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol 2013; 132:476-8.e2.
61. Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A et al. The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012; 129:448-55, 55.e1-5.
62. Leung DY, Sampson HA, Yunginger JW et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348:986-93.
63. Schneider LC, Rachid R, LeBovidge J, Blood E, Mittal M, Umetsu DT. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol 2013; 132:1368-74.
64. Begin P, Winterroth LC, Dominguez T et al. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol 2014; 10:1.
65. Begin P, Dominguez T, Wilson SP et al. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab. Allergy Asthma Clin Immunol 2014; 10:7.
66. Yeung JP, Kloda LA, McDevitt J, Ben-Shoshan M, Alizadehfar R. Oral immunotherapy for milk allergy. Cochrane Database Syst Rev 2012; 11:CD009542.
67. Wasserman RL, Factor JM, Baker JW et al. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract 2014; 2:91-6.
68. Chatchatee P, Jarvinen KM, Bardina L, Beyer K, Sampson HA. Identification of IgE- and IgG-binding epitopes on alpha(s1)-casein: differences in patients with persistent and transient cow's milk allergy. J Allergy Clin Immunol 2001; 107:379-83.
69. Cooke SK, Sampson HA. Allergenic properties of ovomucoid in man. J Immunol 1997; 159:2026-32.
70. Martos G, Lopez-Exposito I, Bencharitiwong R, Berin MC, Nowak-Wegrzyn A. Mechanisms underlying differential food allergy response to heated egg. J Allergy Clin Immunol 2011; 127:990-7.e1-2.
71. Kato Y, Oozawa E, Matsuda T. Decrease in antigenic and allergenic potentials of ovomucoid by heating in the presence of wheat flour: dependence on wheat variety and intermolecular disulfide bridges. J Agri Food Chem 2001; 49:3661-5.
72. Lemon-Mule H, Sampson HA, Sicherer SH, Shreffler WG, Noone S, Nowak-Wegrzyn A. Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 2008; 122:977-83.e1.
73. Nowak-Wegrzyn A, Bloom KA, Sicherer SH et al. Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol 2008; 122:342-7, 7.e1-2.
74. Clark A, Islam S, King Y et al. A longitudinal study of resolution of allergy to well-cooked and uncooked egg. Clin Exp Allergy 2011; 41:706-12.
75. Bartnikas LM, Sheehan WJ, Larabee KS, Petty C, Schneider LC, Phipatanakul W. Ovomucoid is not superior to egg white testing in predicting tolerance to baked egg. J Allergy Clin Immunol Pract 2013; 1:354-60.
76. Bartnikas LM, Sheehan WJ, Hoffman EB et al. Predicting food challenge outcomes for baked milk: role of specific IgE and skin prick testing. Ann Allergy Asthma Immunol 2012; 109:309-13.e1.
77. Lieberman JA, Huang FR, Sampson HA, Nowak-Wegrzyn A. Outcomes of 100 consecutive open, baked-egg oral food challenges in the allergy office. J Allergy Clin Immunol 2012; 129:1682-4.e2.
78. Kim JS, Nowak-Wegrzyn A, Sicherer SH, Noone S, Moshier EL, Sampson HA. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol 2011; 128:125-31.e2.
79. Leonard SA, Sampson HA, Sicherer SH et al. Dietary baked egg accelerates resolution of egg allergy in children. J Allergy Clin Immunol 2012; 130:473-80.e1.
80. Konstantinou GN, Giavi S, Kalobatsou A et al. Consumption of heat-treated egg by children allergic or sensitized to egg can affect the natural course of egg allergy: hypothesis-generating observations. J Allergy Clin Immunol 2008; 122:414-5.
81. Huang F, Nowak-Wegrzyn A. Extensively heated milk and egg as oral immunotherapy. Curr Opin Allergy Clin Immunol 2012; 12:283-92.
82. Konstantinou GN, Kim JS. Paradigm shift in the management of milk and egg allergy: baked milk and egg diet. Immunol Allergy Clin North Am 2012; 32:151-64.
83. Clark AT, Skypala I, Leech SC et al. British Society for Allergy and Clinical Immunology guidelines for the management of egg allergy. Clin Exp Allergy 2010; 40:1116-29.
84. Caubet JC, Nowak-Wegrzyn A, Moshier E, Godbold J, Wang J, Sampson HA. Utility of casein-specific IgE levels in predicting reactivity to baked milk. J Allergy Clin Immunol 2013; 131:222-4.e1-4.
85. Caubet JC, Bencharitiwong R, Moshier E, Godbold JH, Sampson HA, Nowak-Wegrzyn A. Significance of ovomucoid- and ovalbumin-specific IgE/IgG(4) ratios in egg allergy. J Allergy Clin Immunol 2012; 129:739-47.
86. Ando H, Moverare R, Kondo Y et al. Utility of ovomucoid-specific IgE concentrations in predicting symptomatic egg allergy. J Allergy Clin Immunol 2008; 122:583-8.
87. Bartnikas LM, Phipatanakul W. Turning up the heat on skin testing for baked egg allergy. Clin Exp Allergy 2013; 43:1095-6.
88. Groetch M, Nowak-Wegrzyn A. Practical approach to nutrition and dietary intervention in pediatric food allergy. Pediatr Allergy Immunol 2013; 24:212-21.
89. Nowak-Wegrzyn A, Groetch M. Let them eat cake. Ann Allergy Asthma Immunol 2012; 109:287-8.
90. Reboucas Jde S, Irache JM, Camacho AI et al. Development of poly(anhydride) nanoparticles loaded with peanut proteins: the influence of preparation method on the immunogenic properties. Eur J Pharm Biopharm 2012; 82:241-9.
91. Kawakita A, Shirasaki H, Yasutomi M et al. Immunotherapy with oligomannose-coated liposomes ameliorates allergic symptoms in a murine food allergy model. Allergy 2012; 67:371-9.
92. Pascal M, Konstantinou GN, Masilamani M, Lieberman J, Sampson HA. In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children. Clin Exp Allergy 2013; 43:116-27.
93. Prickett SR, Voskamp AL, Phan T et al. Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic. Clin Exp Allergy 2013; 43:684-97.
94. Buchanan AD, Green TD, Jones SM et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007; 119:199-205.
95. Kim EH, Bird JA, Kulis M et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 2011; 127:640-6.e1.
96. Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH. Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 2010; 125:1165-7.
97. Dupont CBT, de Blay F, Guenard-Bilbault L et al. Peanut epicutaneous immunotherapy (EPIT) is peanut-allergic children: 18 months treatment in the Arachild Study. J Allergy Clin Immunol 2014; 133:AB 102.
98. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99(6 Pt 1):744-51.
99. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90:256-62.
100. Wood RA, Sicherer SH, Burks AW et al. A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy 2013; 68:803-8.